The Asia Pacific ENT Devices Market would witness market growth of 5.9% CAGR during the forecast period (2022-2028).
The ability to sustain healthy relationships may be hampered by hearing loss. Additionally, hearing loss makes it challenging to follow conversations in social settings, particularly if the environment is noisy. This makes people avoid social events, which may have a negative impact on friendship connections. In some circumstances, isolating oneself raises the risk of mental health problems like depression.
However, going to an audiologist and getting fitted for hearing aids increases the capacity to interact socially, protecting the connections. The demand for the flexible endoscope throughout the course of the analysis will be driven by the broad range of applications for flexible endoscopy in micro-invasive techniques. Flexible endoscope demand will increase as a result of newly designed endoscopes that improve patient safety and reduce exposure to chemical germicides and other microbial illnesses.
The number of elderly people has increased dramatically, which has increased the frequency of ENT problems and increased the rate of sinusitis among big populations, fueling demand for the ENT devices market. Additionally, there are now more minimally invasive ENT procedures available for a variety of illnesses due to the public's growing preference for such treatments.
The sector's rapid expansion is backed by improvements in healthcare services, coverage, and spending by both public and private participants. In fact, since the Covid-19 pandemic, the Indian healthcare system has been under more pressure to become self-sufficient, with attention now being paid to innovation and research, the production of drugs and medical equipment, the digitalization of health services, mental health, fair access to healthcare solutions, and wellness.
The China market dominated the Asia Pacific ENT Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $2,360.1 million by 2028.The Japan market is estimated to grow a CAGR of 5.3% during (2022 - 2028). Additionally, The India market would experience a CAGR of 6.6% during (2022 - 2028).
Based on End-use, the market is segmented into Hospitals & Ambulatory Surgical Centers, ENT Clinics and Homecare. Based on Product, the market is segmented into Surgical ENT Devices, Diagnostics ENT Devices, Hearing Implants, Hearing Implants and Nasal Splints. Based on Surgical ENT Devices Type, the market is segmented into ENT Hand Instruments, Sinus Dilation Devices, Otological Drill Burrs, Radiofrequency Handpieces and Others. Based on Diagnostic ENT Devices Type, the market is segmented into Rigid Endoscopes H2, Flexible Endoscopes, Robot Assisted Endoscope and Hearing Screening Device. Based on Rigid Endoscopes Type, the market is segmented into Sinuscope, Otoscopes and Others. Based on Flexible Endoscopes Type, the market is segmented into Bronchoscopes, Laryngoscopes and Nasopharyngoscopes. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide ENT Devices Market is Projected to reach USD 30.7 Billion by 2028, at a CAGR of 5.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Smith & Nephew PLC, Sonova Holding AG, GN Store Nord A/S, Ambu A/S, Stryker Corporation, Karl Storz SE & Co. KG, Olympus Corporation, Richard Wolf GmbH, Cochlear, Ltd., and Starkey Laboratories, Inc.
By End-use
By Product
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.